Jewish General Hospital
|Sir Mortimer B. Davis Jewish General Hospital|
Hôpital général juif Sir Mortimer B. Davis
3755, chemin de la Côte-Sainte-Catherine|
Montreal, Quebec, Canada
|Care system||RAMQ (Quebec Health Insurance Board)|
|Affiliated university||McGill University|
|Emergency department||Level II trauma center|
The Jewish General Hospital (JGH; French: Hôpital général juif), known officially as the Sir Mortimer B. Davis Jewish General Hospital (French: Hôpital général juif Sir Mortimer B. Davis) since 1978, is an acute-care teaching hospital in Montreal, Quebec, Canada. Affiliated with McGill University, it has 637 beds.
The Jewish General Hospital, which opened its doors in 1934, was founded as a general hospital, open to all patients regardless of race, religion, language or ethnic background. While part of the Quebec medicare system, and functionally bilingual in French and English, the hospital continues to be run chiefly by members of the Jewish community.
At his death in 1928, Mortimer Davis left most of his estate to be used for the construction of a Jewish public hospital that would bear his name. In 1969, the hospital opened the affiliated Lady Davis Institute for Medical Research, one of the largest and most influential research centres in Canada.
Among many other medical innovations, in 1974, the JGH was one of the first hospitals in Canada to open a division of colorectal surgery. Among the famous alumni of the hospital is former head nurse Beverley Binder (née Rosen).
In 1978, fifty years after Davis's death, $10 million from his estate was donated to the Jewish General Hospital, which was then renamed the Sir Mortimer B. Davis Jewish General Hospital.
Lady Davis Institute for Medical Research
The Lady Davis Institute for Medical Research (LDI) is the research arm of the Sir Mortimer B. Davis Jewish General Hospital and has strong academic ties to McGill University.
Founded in 1969, the LDI has a roster of nearly 200 researchers, and it is an important North American biomedical research institute. LDI researchers have made major breakthroughs in the areas of HIV/AIDS, aging, cancer, vascular disease, epidemiology, and psychosocial science.
The LDI currently supports four major research axes (or programs):
- Cancer (Segal Cancer Centre)
- Molecular and Regenerative Medicine (includes stem cells, haemovascular disease, aging and HIV/AIDS)
- Psychosocial Aspects of Disease